CompanyGraph
Sign in
The Story of Straumann

The Story of Straumann

A dental implant becomes a treatment only when a qualified device, a patient's anatomy, a trained clinician, a laboratory, and long-term maintenance remain connected.

The implant is not the restoration

An implant has a material, geometry, surface, connection, and manufacturing history. A clinician still needs imaging, planning, drilling, placement, healing, an abutment, a crown, and follow-up. The patient's bone, hygiene, systemic health, and bite determine what the finished restoration can tolerate.

Straumann's 2025 Annual Report describes implants, prosthetics, orthodontics, digital solutions, education, and its global business. Revenue and units sold show market activity; they do not establish the outcome of an individual treatment.

Training is part of the product route

Digital planning and guided surgery can make a procedure more repeatable, but they add scanners, software, files, laboratory steps, and training. A clinician may own the hardware and still lack the case volume or support to use a workflow safely. Switching systems can require new instruments, connections, and clinical habits.

Clinical lock-in is created by a completed treatment pathway, not by the implant in its package.

Money determines which treatment is possible

Patients and clinics must finance imaging, surgery, laboratory work, training, and follow-up before the final restoration is paid. Reimbursement or patient affordability can determine whether the ideal material, staged procedure, or maintenance visit occurs. Straumann's education and distribution help, but clinicians and patients retain the decisive authority.

Evidence follows the patient

A lot certificate establishes a device's manufacturing history. A surgical record establishes what was placed. A radiograph shows one stage of bone and fit. A warranty or complaint records a later problem. None alone proves long-term clinical success. Correction needs lot, site, clinician, patient, prosthesis, and time to remain connected.

Straumann's durable position is the coordination of materials, digital planning, professional education, laboratories, and patient care. The product's life extends far beyond the sale, and the clinical result remains a separate observation from revenue or procedure count.

Related

The Story of Stryker

Stryker's products become useful inside surgery, where implants, instruments, imaging, software, operating-room teams, and a patient's anatomy must line up. Training and standardised workflows can make a system easier to use and harder to replace. The clinical result still depends on the patient, surgeon, hospital, maintenance, sterilisation, and follow-up beyond the product sale.

The Story of Symrise

Symrise operates upstream of products that consumers rarely see as chemical systems. Its ingredients affect taste, smell, texture, preservation, skin care, and nutrition, but their value appears only after formulation, testing, regulatory review, manufacturing, and consumer use. Long customer relationships can protect a formulation, while a molecule, specification, or shipment remains only one part of the finished result.

How to Find Beaten-Down Stocks With Strong Fundamentals

Shows how to screen for stocks at least 35% below a two-year high with strong latest-year OCF-to-net-income and consistent eight-year revenue growth, then test risks, segments, valuation, and catalysts.